DIN 01916882 — CLAVULIN 125 F ORAL SUS 31.25 MG; 125 MG
CLAVULIN 125 F ORAL SUS is a powder for suspension of Amoxicillin / Clavulanic Acid marketed by GLAXOSMITHKLINE INC. The full Amoxicillin / Clavulanic Acid monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 01916882
- Brand name
- CLAVULIN 125 F ORAL SUS
- Active ingredient
- Amoxicillin / Clavulanic Acid
- Strength
- 31.25 MG; 125 MG
- Dosage form
- POWDER FOR SUSPENSION
- Route
- ORAL
- Manufacturer
- GLAXOSMITHKLINE INC
- Health Canada status
- MARKETED
- Drug class
- Penicillin antibiotic with beta-lactamase inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Amoxicillin / Clavulanic Acid products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02510634 | AG-AMOXI CLAV | 500 MG; 125 MG | TABLET | ANGITA PHARMA INC. | MARKETED |
| 02510642 | AG-AMOXI CLAV | 875 MG; 125 MG | TABLET | ANGITA PHARMA INC. | MARKETED |
| 02495929 | AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION | 200 MG; 1000 MG | POWDER FOR SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02495937 | AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION | 2000 MG; 200 MG | POWDER FOR SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02495910 | AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION | 500 MG; 100 MG | POWDER FOR SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02536048 | AMOXICILLIN/CLAV | 125 MG; 875 MG | TABLET | SANIS HEALTH INC | MARKETED |
| 02536021 | AMOXICILLIN/CLAV | 500 MG; 125 MG | TABLET | SANIS HEALTH INC | MARKETED |
| 02243350 | APO-AMOXI CLAV | 125 MG; 250 MG | TABLET | APOTEX INC | MARKETED |
| 02288559 | APO-AMOXI CLAV | 400 MG; 57 MG | POWDER FOR SUSPENSION | APOTEX INC | DORMANT |
| 02243351 | APO-AMOXI CLAV | 500 MG; 125 MG | TABLET | APOTEX INC | MARKETED |
| 02245623 | APO-AMOXI CLAV | 875 MG; 125 MG | TABLET | APOTEX INC | MARKETED |
| 02243987 | APO-AMOXI CLAV 250MG/62.5MG PER 5ML | 62.5 MG; 250 MG | POWDER FOR SUSPENSION | APOTEX INC | DORMANT |
| 02471671 | AURO-AMOXICLAV | 125 MG; 250 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02471698 | AURO-AMOXICLAV | 125 MG; 500 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02471701 | AURO-AMOXICLAV | 875 MG; 125 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02238831 | CLAVULIN 200 | 200 MG; 28.5 MG | POWDER FOR SUSPENSION | GLAXOSMITHKLINE INC | MARKETED |
| 01916874 | CLAVULIN 250 F ORAL SUS | 62.5 MG; 250 MG | POWDER FOR SUSPENSION | GLAXOSMITHKLINE INC | MARKETED |
| 02238830 | CLAVULIN 400 | 57 MG; 400 MG | POWDER FOR SUSPENSION | GLAXOSMITHKLINE INC | MARKETED |
| 02508249 | JAMP AMOXI CLAV | 125 MG; 250 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02508265 | JAMP AMOXI CLAV | 125 MG; 875 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02508257 | JAMP AMOXI CLAV | 500 MG; 125 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02539411 | JAMP AMOXI CLAV SUSPENSION | 200 MG; 28.5 MG | POWDER FOR SUSPENSION | JAMP PHARMA CORPORATION | DORMANT |
| 02539446 | JAMP AMOXI CLAV SUSPENSION | 400 MG; 57 MG | POWDER FOR SUSPENSION | JAMP PHARMA CORPORATION | MARKETED |
| 02539438 | JAMP AMOXI CLAV SUSPENSION | 62.5 MG; 250 MG | POWDER FOR SUSPENSION | JAMP PHARMA CORPORATION | MARKETED |
| 02530694 | M-AMOXI CLAV | 400 MG; 57 MG | POWDER FOR SUSPENSION | MANTRA PHARMA INC | MARKETED |
| 02542226 | M-AMOXI CLAV | 62.5 MG; 250 MG | POWDER FOR SUSPENSION | MANTRA PHARMA INC | MARKETED |
| 02536498 | PRO-AMOXI CLAV | 500 MG; 125 MG | TABLET | PRO DOC LIMITEE | MARKETED |
| 02536501 | PRO-AMOXI CLAV | 875 MG; 125 MG | TABLET | PRO DOC LIMITEE | MARKETED |
| 02482584 | SANDOZ AMOXI-CLAV TABLET | 125 MG; 875 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02482576 | SANDOZ AMOXI-CLAV TABLET | 500 MG; 125 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |